Retour
46
24
Fourchette du Jour
95,21 €
96,74 €
Fourchette 52 Semaines
65,88 €
107,50 €
Volume
6 452 542
Moyenne 50J / 200J
98,24 €
/
95,34 €
Clôture Précédente
95,30 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Financial Services (854 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,2 | 10,3 |
| P/B | 3,4 | 1,1 |
| ROE % | 18,1 | 11,7 |
| Net Margin % | 32,0 | 16,9 |
| Rev Growth 5Y % | 9,9 | 11,6 |
| D/E | 0,7 | 0,5 |
Objectif de Cours des Analystes
Hold
122,78 €
+28.3%
Low: 105,00 €
High: 148,00 €
P/E Prévisionnel
16,2
BPA Prévisionnel
5,88 €
Croissance BPA (est.)
+0,0%
CA Est.
26 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
9,65 €
9,09 € – 10,08 €
|
36 B | 2 |
| FY2029 |
8,81 €
8,30 € – 9,21 €
|
34 B | 2 |
| FY2028 |
7,91 €
6,54 € – 8,45 €
|
32 B | 4 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 |
Verdeschi Michael D
CFO
|
grant | 62 134 | — | — |
| Mar 2, 2026 |
Craig Jonathan M.
MD, Head of Investor Services
|
grant | 50 052 | — | — |
| Mar 2, 2026 |
Beatty Jonathan S
MD, Head of Advisor Services
|
grant | 24 509 | — | — |
| Mar 1, 2026 |
Craig Jonathan M.
MD, Head of Investor Services
|
grant | 25 633 | — | — |
| Mar 1, 2026 |
Craig Jonathan M.
MD, Head of Investor Services
|
other | 11 152 | 95,31 € | 1 062 841 € |
| Nov 19, 2025 |
Ruffel Charles A.
Director
|
other | 8 372 | — | — |
| Nov 10, 2025 |
Schwab-Pomerantz Carolyn
Director
|
other | 298 | — | — |
| Nov 10, 2025 |
Bettinger Walter W
Co-Chairman
|
other | 61 388 | — | — |
| Oct 29, 2025 |
Woolway Paul V
MD, Chief Banking Officer
|
other | 3 823 | — | — |
| Oct 1, 2025 |
Brown Marianne Catherine
Director
|
grant | 407 | — | — |
| Jul 29, 2025 |
Wurster Richard A
President & CEO
|
sell | 20 500 | 99,16 € | 2 032 852 € |
| Jul 1, 2025 |
Brown Marianne Catherine
Director
|
grant | 412 | — | — |
| Jul 1, 2025 |
Ruffel Charles A.
Director
|
grant | 1 322 | — | — |
| Jun 24, 2025 |
Ellis Stephen A
Director
|
other | 3 706 | 33,12 € | — |
| Jun 3, 2025 |
Verdeschi Michael D
CFO
|
other | 5 888 | 87,54 € | 515 436 € |
| Jun 2, 2025 |
Woolway Paul V
MD, Chief Banking Officer
|
sell | 3 290 | 87,68 € | 288 452 € |
| May 27, 2025 |
Dea Joan
Director
|
grant | 5 108 | — | — |
| May 27, 2025 |
Ruffel Charles A.
Director
|
grant | 5 108 | — | — |
| May 27, 2025 |
ADAMS JOHN K JR
Director
|
grant | 5 108 | — | — |
| May 27, 2025 |
Brown Marianne Catherine
Director
|
grant | 5 108 | — | — |
Points Clés
Revenue grew 9,86% annually over 5 years — modest growth
Earnings grew 48,97% over the past year
ROE of 18,11% — decent returns on equity
Net margin of 31,99% shows strong profitability
Generating 8,76B in free cash flow
PEG of 0,36 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
9,86%
Revenue (1Y)6,45%
Earnings (1Y)48,97%
FCF Growth (3Y)-31,88%
Qualité
Return on Equity
18,11%
ROIC12,62%
Net Margin31,99%
Op. Margin49,42%
Sécurité
Debt / Equity
0,65
Current Ratio17,83
Interest Coverage3,64
Valorisation
P/E Ratio
19,21
P/B Ratio3,44
EV/EBITDA14,74
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,45% | Revenue Growth (3Y) | 4,13% |
| Earnings Growth (1Y) | 48,97% | Earnings Growth (3Y) | 32,17% |
| Revenue Growth (5Y) | 9,86% | Earnings Growth (5Y) | 10,89% |
| Profitability | |||
| Revenue (TTM) | 27,68B | Net Income (TTM) | 8,85B |
| ROE | 18,11% | ROA | 1,80% |
| Gross Margin | 80,28% | Operating Margin | 49,42% |
| Net Margin | 31,99% | Free Cash Flow (TTM) | 8,76B |
| ROIC | 12,62% | FCF Growth (3Y) | -31,88% |
| Safety | |||
| Debt / Equity | 0,65 | Current Ratio | 17,83 |
| Interest Coverage | 3,64 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 19,21 | P/B Ratio | 3,44 |
| P/S Ratio | 6,14 | PEG Ratio | 0,36 |
| EV/EBITDA | 14,74 | Dividend Yield | 0,01% |
| Market Cap | 170,02B | Enterprise Value | 201,59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27,68B | 26,00B | 25,52B | 22,31B | 19,00B |
| Net Income | 8,85B | 5,94B | 5,07B | 7,18B | 5,86B |
| EPS (Diluted) | 4,66 | 2,99 | 2,54 | 3,50 | 2,83 |
| Gross Profit | 22,22B | 19,61B | 18,84B | 20,76B | 18,52B |
| Operating Income | 13,68B | 7,69B | 6,38B | 9,39B | 7,71B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 491,00B | 479,84B | 493,18B | 551,77B | 667,27B |
| Total Liabilities | 441,57B | 431,47B | 452,22B | 515,16B | 611,01B |
| Shareholders' Equity | 49,40B | 48,38B | 40,96B | 36,61B | 56,26B |
| Total Debt | 31,87B | 45,13B | 59,08B | 37,88B | 23,77B |
| Cash & Equivalents | 292,00M | 42,08B | 43,34B | 40,20B | 62,98B |
| Current Assets | 200,80B | 215,38B | 224,62B | 259,27B | 548,32B |
| Current Liabilities | 11,26B | 396,72B | 414,34B | 494,34B | 592,10B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#489 of 1052
Custom
Capital Light Compounder
#189 of 218
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026